| 1/2 | US=84-A / Biol/Mol Ling LE, Singh J, Chuaqui CE, Boriack-Sjodin PA, Corbley MJ, Lepage DJ, Silverio EL, Sun L, Papadatos JL, Shan F, Pontz T, Kam Cheung H, Zhang X, Arduini RM, Mead JN, Newman MN, Bowes S, Josiah S, Lee WC. Development of inhibitors of transforming growth factor-B signaling for therapy: the use of virtual screening in ALK5 kinase inhibitor discovery and validation of orally active ALK5 kinase inhibitors in oncology. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 685-96. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. VIRTUAL; FARMACOFORO; INIBIDOR DE CINASE; ALK5; TGF-B RECEPTOR TIPO I; CRISTALOGRAFIA DE RAIOS X; TGF-B |
| 2/2 | US=90 / Biol/Mol Eigenbrot C. EGFR signaling networks: structure-function of EGFR kinase domain and its inhibitors. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 31-45. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. CRISTALOGRAFIA DE RAIOS X; INIBIDOR DE MOLECULA PEQUENA; ESCAPAR MUTACAO; ACTIVACAO DA CINASE; ALLOSTERY; L858R; T790M |